Axa
BVS icon

Axa’s Bioventus BVS Stock Holding History

Axa’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,424
Closed -$109K – 1062
2024
Q4 		$109K Hold
10,424
– – ﹤0.01% 1046
2024
Q3 		$125K Hold
10,424
– – ﹤0.01% 1065
2024
Q2 		$59.9K Hold
10,424
– – ﹤0.01% 1042
2024
Q1 		$54.2K Hold
10,424
– – ﹤0.01% 1048
2023
Q4 		$54.9K Buy
+10,424
New +$41.2K ﹤0.01% 1050

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Axa's BVS Position: Q1 2025 in Review

Axa sold out of Bioventus (BVS) in Q1 2025, closing a stake of 10,424 shares — an estimated $109K sold.

Axa first reported a position in BVS in Q4 2023 and held it in 5 quarters. The position peaked at $125K in Q3 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Axa reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Axa sold 10,424 Bioventus shares in Q1 2025, an estimated $109K.
  • Axa first reported a position in Bioventus in Q4 2023 and held it in 5 quarters.
  • Axa's Bioventus position peaked at $125K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.